Safety and effectiveness of oral medium to high dose blonanserin in patients with schizophrenia: subgroup analysis from a prospective, multicenter, post-marketing surveillance study in mainland China

Safety and Effectiveness of Blonanserin in Chinese Patients with Schizophrenia: An Interim Analysis of a 12-Week Open-Label Prospective Multi-Center Post-marketing Surveillance

(2022) Haishan Wu et al.   Frontiers in Psychiatry

Antipsychotic Dose in Acute Schizophrenia: A Meta-analysis

(2020) Hiroyoshi Takeuchi et al.   SCHIZOPHRENIA BULLETIN

Efficacy, Tolerability, and Safety of Blonanserin in Schizophrenia: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled Trials

(2018) Taro Kishi et al.   PHARMACOPSYCHIATRY

Racial/ethnic differences in drug disposition and response: Review of recently approved drugs

(2015) A Ramamoorthy et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Comparative study of the efficacy and safety between blonanserin and risperidone for the treatment of schizophrenia in Chinese patients: A double-blind, parallel-group multicenter randomized trial

(2015) Huafang Li et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Striatal and Extrastriatal Dopamine D2 Receptor Occupancy by a Novel Antipsychotic, Blonanserin

(2013) Amane Tateno et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance

(2012) Alkomiet Hasan et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

The Efficacy and Safety of Blonanserin Compared with Haloperidol in Acute-Phase Schizophrenia

(2009) Esther Garcia et al.   CNS DRUGS

Blonanserin

(2009) Emma D. Deeks et al.   CNS DRUGS

Is This the Drug or Dose for You?: Impact and Consideration of Ethnic Factors in Global Drug Development, Regulatory Review, and Clinical Practice

(2008) S-M Huang et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS